Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Utility of LymphoScan Imaging in the Localization and Staging of Patients With Non-Hodgkin's Lymphoma

NCT00003337 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00003337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Utility of LymphoScan Imaging in the Localization and Staging of Patients With Non-Hodgkin's Lymphoma
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 1997
Completion date
Not reported
Enrollment
100 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma